⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2116183 | 0.77 | — | — | |
| SCHEMBL2116944 | 0.77 | — | — | |
| SCHEMBL7145471 | 0.75 | — | — | |
| SCHEMBL9299363 | 0.74 | ALDH1A1 (0.43) | — | |
| SCHEMBL1701047 | 0.72 | — | — | |
| SCHEMBL31265934 | 0.71 | GPR84 (0.40) | — | |
| SCHEMBL5814834 | 0.71 | IDH1 (0.53) | — | |
| SCHEMBL1187892 | 0.69 | — | — | |
| SCHEMBL8850526 | 0.67 | NQO1 (0.31) | — | |
| SCHEMBL7796741 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109734929-B | Preparation method and application of maltol magnetic molecularly imprinted solid-phase extraction material with core-shell microsphere structure | 安徽中烟工业有限责任公司 | 2021-07-13 | — | — | CN | claimed |
| EP-3542780-B1 | SERIES OF SKIN-WHITENING (LIGHTENING) COMPOUNDS | UNIGEN INC (US) | 2022-01-19 | — | — | EP | disclosed |
| CN-109734929-B | Preparation method and application of maltol magnetic molecularly imprinted solid-phase extraction material with core-shell microsphere structure | 安徽中烟工业有限责任公司 | 2021-07-13 | — | — | CN | disclosed |
| EP-3697763-A1 | D-AMINO ACID OXIDASE INHIBITORS AND THERAPEUTIC USES THEREOF | Syneurx International (Taiwan) Corp. (TW) | 2020-08-26 | — | — | EP | disclosed |
| WO-2019076329-A9 | D-AMINO ACID OXIDASE INHIBITORS AND THERAPEUTIC USES THEREOF | TSAI GUOCHUAN EMIL (CN) | 2019-08-15 | — | — | WO | disclosed |
| EP-2323612-B1 | SERIES OF SKIN-WHITENING (LIGHTENING) COMPOUNDS | UNIGEN INC (US) | 2019-07-10 | — | — | EP | disclosed |
| WO-2019076329-A1 | D-AMINO ACID OXIDASE INHIBITORS AND THERAPEUTIC USES THEREOF | TSAI GUOCHUAN EMIL (CN) | 2019-04-25 | — | — | WO | disclosed |
| CN-108473458-A | Bigcatkin willow acid derivative compound, preparation method and the skin-lightening cosmetic constituent comprising the compound | 爱茉莉太平洋股份有限公司 | 2018-08-31 | — | — | CN | disclosed |
| US-8247581-B2 | Process for converting cellulose in a liquid biofuel using N-methyl imidazolium chloride | Correia, Pedro B (PT) | 2012-08-21 | — | — | US | disclosed |
| US-20100305340-A1 | Biocell - Three step process for obtaining a liquid biofuel from cellulose consisting mainly of isomers of methylpyran and methyl tetrahydropyran using N alkyl imidazol chloride as solvent and catalyst | CORREIA PEDRO BRITO DA SILVA | 2010-12-02 | — | — | US | disclosed |
| WO-2010082075-A1 | BIOCELL - LIQUID BIOFUEL CONSISTING OF ISOMERS OF METHYLPYRAN AND METHYLTETRAHYDROPYRAN AND A PROCESS FOR OBTAING IT FROM CELLULOSE IN A ONE STEP REACTION | INVENTUS, PRODUTOS QUIMICOS LDA (PT) | 2010-07-22 | — | — | WO | disclosed |
| EP-1973518-A1 | SYNERGISTIC ACTIVE PREPARATIONS COMPRISING DIPHENYLMETHANE DERIVATIVES AND FURTHER SKIN AND/OR HAIR LIGHTENING AND/OR SENILE KERATOSIS REDUCING COMPOUNDS | Symrise GmbH & Co. KG (DE) | 2008-10-01 | — | — | EP | disclosed |
| WO-2007077259-A9 | SYNERGISTIC ACTIVE PREPARATIONS COMPRISING DIPHENYLMETHANE DERIVATIVES AND FURTHER SKIN AND/OR HAIR LIGHTENING AND/OR SENILE KERATOSIS REDUCING COMPOUNDS | SYMRISE GMBH & CO KG (DE) | 2007-09-20 | — | — | WO | disclosed |
| WO-2007077259-A1 | SYNERGISTIC ACTIVE PREPARATIONS COMPRISING DIPHENYLMETHANE DERIVATIVES AND FURTHER SKIN AND/OR HAIR LIGHTENING AND/OR SENILE KERATOSIS REDUCING COMPOUNDS | SYMRISE GMBH & CO. KG (DE) | 2007-07-12 | — | — | WO | disclosed |
| US-20050054629-A1 | Compounds and methods of treating cell proliferative diseases | EXONHIT THERAPEUTICS SA (FR) | 2005-03-10 | — | — | US | disclosed |
| EP-1480966-A1 | COMPOUNDS AND METHODS OF TREATING CELL PROLIFERATIVE DISEASES | Exonhit Therapeutics S.A. (FR) | 2004-12-01 | — | — | EP | disclosed |
| WO-2003074508-A1 | COMPOUNDS AND METHODS OF TREATING CELL PROLIFERATIVE DISEASES | EXONHIT THERAPEUTICS SA (FR) | 2003-09-12 | — | — | WO | disclosed |
| US-6552073-B1 | As anti-proliferative agent; for therapy of cancer | EXONHIT THERAPEUTICS SA (FR) | 2003-04-22 | — | — | US | disclosed |